Shan-shan Chen

发表

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2011, Blood.

MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation‐negative chronic myeloproliferative disorders detected by a newly developed RQ‐PCR based on TaqMan MGB probes

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Hematological oncology.

Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2010, Annals of Hematology.

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2010, Annals of Hematology.

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.

Ya-Zhen Qin, B. Jiang, Yan-rong Liu, 2009, Leukemia research.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

[Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].

Ya-Zhen Qin, Yan-rong Liu, G. Ruan, 2003, Zhongguo shi yan xue ye xue za zhi.

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

Hao Jiang, R. Gale, Hao Jiang, 2016, BMC Cancer.

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Yan Liu, Hao Jiang, Q. Jiang, 2008, Acta Haematologica.

High frequency of IKZF1 deletions in Chinese adult patients with acute lymphoblastic leukemia detected by multiplex real-time quantitative PCR

Li-xin Wu, Yan-rong Liu, Xiao-jun Huang, 2017 .

Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo

Yan-rong Liu, Xiao-jun Huang, G. Ruan, 2008, Apoptosis.

[Standardization and Quality Control in Flow Cytometric Enumeration of CD34(+) cells]

Yan-rong Liu, Hong-gang Yu, Shan-shan Chen, 2000, Zhongguo shi yan xue ye xue za zhi.

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.

B. Jiang, Yan-rong Liu, Qin Wang, 2002, Blood.

The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2014, Molecular Cancer.

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.

Q. Jiang, Yan-rong Liu, G. Ruan, 2011, Leukemia research.

Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.

Yan-rong Liu, G. Ruan, Xi Ma, 2006, Leukemia research.

A population association study of vitamin D receptor gene polymorphisms and haplotypes with the risk of systemic lupus erythematosus in a Chinese population

Shan-shan Chen, Pu Chen, Jin Lu, 2017, Immunologic Research.

Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.

Yan-rong Liu, G. Ruan, Hong-gang Yu, 2004, Leukemia research.

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2009, Annals of Hematology.

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

R. Gale, Hao Jiang, Q. Jiang, 2016, BMC Cancer.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.

A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms

R. Gale, G. Ruan, Jiao Zhou, 2015, Hematology.

[Expression of Vascular Endothelial Growth Factor in the Bone Marrow Cells from Adult Chronic Myelogenous Leukemia]

Yan-rong Liu, G. Ruan, Ren-kui Bai, 2001, Zhongguo shi yan xue ye xue za zhi.

[Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].

Shan-shan Chen, 2006, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[The efficacy of imatinib mesylate for 124 patients with chronic myeloid leukemia in accelerated and blastic phase].

Hao Jiang, Q. Jiang, B. Jiang, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[Efficacy and safety evaluation of imatinib in the treatment of patients with chronic granulocytic leukemia in accelerated phase].

Hao Jiang, Q. Jiang, B. Jiang, 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Different kinetic patterns of BCR‐ABL transcript levels in imatinib‐treated chronic myeloid leukemia patients after achieving complete cytogenetic response

Hao Jiang, Xiao-jun Huang, G. Ruan, 2008, International journal of laboratory hematology.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

Hao Jiang, Q. Jiang, B. Jiang, 2014, Bone Marrow Transplantation.

[Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].

Yan-rong Liu, Xiao-jun Huang, G. Ruan, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.